Graham K. Cooper
2010 - Orexigen Therapeutics
In 2010, Graham K. Cooper earned a total compensation of $1.1M as Former Chief Financial Officer and Treasurer at Orexigen Therapeutics, a 52% increase compared to previous year.
Compensation breakdown
| Bonus | $160,000 |
|---|---|
| Option Awards | $589,751 |
| Salary | $320,000 |
| Other | $7,470 |
| Total | $1,077,221 |
Cooper received $589.8K in option awards, accounting for 55% of the total pay in 2010.
Cooper also received $160K in bonus, $320K in salary and $7.5K in other compensation.
Rankings
In 2010, Graham K. Cooper's compensation ranked 5,017th out of 10,439 executives tracked by ExecPay. In other words, Cooper earned more than 51.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,017 out of 10,439 | 52nd |
Division Manufacturing | 1,803 out of 3,838 | 53rd |
Major group Chemicals And Allied Products | 371 out of 921 | 60th |
Industry group Drugs | 219 out of 680 | 68th |
Industry Pharmaceutical Preparations | 170 out of 481 | 65th |
Source: SEC filing on April 27, 2012.
Cooper's colleagues
We found five more compensation records of executives who worked with Graham K. Cooper at Orexigen Therapeutics in 2010.
2010
Michael Narachi
Orexigen Therapeutics
Chief Executive Officer
2010
Heather Turner
Orexigen Therapeutics
General Counsel
2010
Mark Booth
Orexigen Therapeutics
Chief Commercial Officer
2010
Preston Klassen
Orexigen Therapeutics
Head of Global Contrave Program and Senior Vice President, Product Development
2010
Joseph Hagan
Orexigen Therapeutics